Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
Strength: 5 mg Format: Sterile vial Intended use: Research use only Storage: Store in a cool, dry place
Week 2: If week 1 was tolerated well, increase to 50% of the target dose
Retatrutide acts as a triple incretin receptor agonist, simultaneously activating three distinct receptors: GLP-1 receptors stimulating insulin secretion in a glucose-dependent manner, slowing gastric emptying, and reducing appetite GIP receptors enhancing insulin release and potentially improving fat metabolism Glucagon receptors increasing energy expenditure and promoting fat breakdown in the liver This multi-receptor activity produces pronounced effects on body weight, blood glucose, lipid metabolism, and hepatic fat
First, the reduction in apoptotic dermal papilla cells on annexin V labelling was not statistically significant
US$ 27.69
US$ 27.05
US$ 29.41
US$ 28.77
